Heart disorders (heart disease)

General Information

Symptoms and Causes

Prevention and Treatment

References

BIBLIOGRAPHY

American Heart Association.
www.americanheart.org

Boekholdt SM, Sandhu MS, Day NE, et al. Physical activity, C-reactive protein levels and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Eur J Cardiovasc Prev Rehabil. 2006;13(6):970-6.
View Article

Centers for Disease Control and Prevention (CDC).
www.cdc.gov

Harris WS, Assaad B, Poston WC. Tissue omega-6/omega-3 fatty acid ratio and risk for coronary artery disease. Am J Cardiol. 2006 Aug 21;98(4A):19i-26i. Epub 2006 May 30.
View Article

Heidemann C, Hoffmann K, Klipstein-Grobusch K, et al. Potentially modifiable classic risk factors and their impact on incident myocardial infarction: results from the EPIC-Potsdam study. Eur J Cardiovasc Prev Rehabil. 2007;14(1):65-71.
View Article

Hoffman T. Risk management of coronary artery disease--pharmacological therapy. Article in German. Wien Med Wochenschr. 2004 Jun;154(11-12):266-81.
View Article

Imazio M, Trinchero R, Shabetai R. Pathogenesis, management, and prevention of recurrent pericarditis. J Cardiovasc Med (Hagerstown). 2007 Jun;8(6):404-10.
View Article

National Heart, Lung, and Blood Institute (NHLBI).
www.nhlbi.nih.gov

National Institutes of Health (NIH).
www.nih.gov

Natural Standard: The Authority on Integrative Medicine.
www.naturalstandard.com

Reis RP, Azinheira J, Reis HP, et al. Prognosis significance of blood homocysteine after myocardial infarction. Article in Portuguese. Rev Port Cardiol. 2000 May;19(5):581-5.
View Article